LIN28 is involved in glioma carcinogenesis and predicts outcomes of glioblastoma multiforme patients

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Qin, Rong ^a   Zhou, Jingxu ^b   Chen, Chao ^a   Xu, Tao ^a   Yan, Yong ^a   Ma, Yushui ^c   Zheng, Zongli ^d   Shen, Yiping ^e   Lu, Yicheng ^a   Fu, Da ^c   Chen, Juxiang ^a,d  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 101 Hospital of Chinese PLA   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN LIN28; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; LIN-28 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIN28 GENE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; BRAIN NEOPLASMS; CANCER GRADING; CELL CYCLE CHECKPOINT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TISSUE MICROARRAY; TUMOR CELL LINE;

APOPTOSIS; BRAIN NEOPLASMS; CARCINOGENESIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS;

EID: 84899853639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086446     Document Type: Article

References (34)

1. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359: 492-507.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
3. Nicholas MK, Lukas RV, Jafri NF, Faoro L, Salgia R (2006) Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res 12: 7261-7270. (Pubitemid 46095397)
4. Hagerstrand D, He X, Bradic Lindh M, Hoefs S, Hesselager G, et al. (2011) Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol 13: 1178-1191.
5. Zhou YH, Tan F, Hess KR, Yung WK (2003) The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clin Cancer Res 9: 3369-3375. (Pubitemid 37082732)
6. Viswanathan SR, Daley GQ, Gregory RI (2008) Selective blockade of microRNA processing by Lin28. Science 320: 97-100. (Pubitemid 351490762)
7. Heo I, Joo C, Cho J, Ha M, Han J, et al. (2008) Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276-284.
8. Hagan JP, Piskounova E, Gregory RI (2009) Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 16: 1021-1025.
9. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647. (Pubitemid 40343076)
10. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677. (Pubitemid 46676103)
11. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579. (Pubitemid 46449474)
12. Yu F, Yao H, Zhu P, Zhang X, Pan Q, et al. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 1109-1123. (Pubitemid 350235025)
13. Peng S, Maihle NJ, Huang Y (2010) Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene 29: 2153-2159.
14. Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, et al. (2009) Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer 45: 2212-2218.
15. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih Ie M, et al. (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3: e2436.
16. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, et al. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 41: 843-848.
17. Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, et al. (2010) Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 31: 1516-1522.
18. Guo Y, Chen Y, Ito H, Watanabe A, Ge X, et al. (2006) Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma. Gene 384: 51-61. (Pubitemid 44755336)
19. King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, et al. (2011) LIN28B promotes colon cancer progression and metastasis. Cancer Res 71: 4260-4268.
20. Saiki Y, Ishimaru S, Mimori K, Takatsuno Y, Nagahara M, et al. (2009) Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells. Ann Surg Oncol 16: 2638-2644.
21. West JA, Viswanathan SR, Yabuuchi A, Cunniff K, Takeuchi A, et al. (2009) A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 460: 909-913.
22. Cao D, Liu A, Wang F, Allan RW, Mei K, et al. (2011) RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod Pathol 24: 288-296.
23. Cao D, Allan RW, Cheng L, Peng Y, Guo CC, et al. (2011) RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum Pathol 42: 710-718.
24. (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
25. Oh JS, Kim JJ, Byun JY, Kim IA (2010) Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 76: 5-8.
26. Zhao T, Xu Y (2010) p53 and stem cells: new developments and new concerns. Trends Cell Biol 20: 170-175.
27. Xu B, Zhang K, Huang Y (2009) Lin28 modulates cell growth and associates with a subset of cell cycle regulator mRNAs in mouse embryonic stem cells. RNA 15: 357-361.
28. Lee ST, Chu K, Oh HJ, Im WS, Lim JY, et al. (2011) Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol 102: 19-24.
29. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, et al. (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844-847. (Pubitemid 28331029)
30. Moss EG, Lee RC, Ambros V (1997) The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88: 637-646. (Pubitemid 27152406)
31. Moss EG, Tang L (2003) Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev Biol 258: 432-442. (Pubitemid 36683139)
32. Boominathan L (2010) The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 5: e10615.
33. Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, et al. (2007) Molecularly targeted therapy for malignant glioma. Cancer 110: 13-24.
34. Chi AS, Wen PY (2007) Inhibiting kinases in malignant gliomas. Expert Opin Ther Targets 11: 473-496. (Pubitemid 46487596)